S. Azad

Cystic fibrosis

The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart–lung transplantation Report—2019; Focus theme: Donor and recipient size match

Models of Lung Transplant Research: a consensus statement from the National Heart, Lung, and Blood Institute workshop

Invasive fungal infections in solid organ transplant recipients

Excellent Clinical Outcomes From a National Donation-After-Determination-of-Cardiac-Death Lung Transplant Collaborative

Acute respiratory distress syndrome

Novel translational approaches to the search for precision therapies for acute respiratory distress syndrome

Vascular Signaling in Allogenic Solid Organ Transplantation – The Role of Endothelial Cells

The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report—2017; Focus Theme: Allograft ischemic time

Co-infections in people with COVID-19: a systematic review and meta-analysis

Extracorporeal Life Support as a Bridge to Lung Transplantation

A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation

Use of Lung Allografts from Brain-Dead Donors after Cardiopulmonary Arrest and Resuscitation

The clinical spectrum of pulmonary aspergillosis

Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis

Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature

Part 8: Post–Cardiac Arrest Care

Normothermic Ex Vivo Lung Perfusion in Clinical Lung Transplantation

Ex Vivo Perfusion Treatment of Infection in Human Donor Lungs

Pretransplant Aspergillus Colonization of Cystic Fibrosis Patients and the Incidence of Post–Lung Transplant Invasive Aspergillosis

Risk Factors for Voriconazole Hepatotoxicity at 12 Weeks in Lung Transplant Recipients

The Effectiveness of Culture-Directed Preemptive Anti-Aspergillus Treatment in Lung Transplant Recipients at One Year After Transplant

De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation

45: Safety and Efficacy of the Novalung Interventional Lung Assist (iLA) Device as a Bridge to Lung Transplantation

258: Ex Vivo Lung Perfusion in Clinical Lung Transplantation – The “HELP” Trial